Your browser doesn't support javascript.
loading
Risk of New Primary Cancer in Patients with Posterior Uveal Melanoma: A National Cohort Study.
Bagger, Mette; Albieri, Vanna; Hindso, Tine Gadegaard; Wadt, Karin; Heegaard, Steffen; Andersen, Klaus Kaae; Kiilgaard, Jens Folke.
Afiliação
  • Bagger M; Department of Ophthalmology, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Albieri V; Statistics and Data Analysis, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
  • Hindso TG; Department of Ophthalmology, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Wadt K; Department of Clinical Genetics, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Heegaard S; Department of Ophthalmology, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Andersen KK; Department of Pathology, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Kiilgaard JF; Statistics and Data Analysis, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Cancers (Basel) ; 14(2)2022 Jan 07.
Article em En | MEDLINE | ID: mdl-35053448
BACKGROUND: Studies on the risk of new primary cancer in patients with posterior uveal melanoma (UM) have produced conflicting results, and the role of socioeconomic status (SES) is unknown. The purpose of this population-based matched cohort study was to determine the risk of new primary cancer following the diagnosis of posterior UM. METHODS: 2179 patients with posterior UM 1968-2016 and 22,717 matched controls without cancer were included. Incidence and time-dependent hazard ratio (HR) of new primary cancer were described, and the effect of SES was emphasized in a sub-cohort. RESULTS: The incidence of new primary cancer was increased in patients with posterior UM, rate ratio (RR) 1.21 (95% CI: 1.08; 1.35), but the specific cancer types did not differ compared to the controls. The rate of new primary cancer following the diagnosis of posterior UM was significantly increased 2-5 years (HR 1.49 (95% CI: 1.23; 1.80)) and 11-15 years (HR: 1.49 (95% CI: 1.12; 1.99)), and adjusting for SES did not change the rate (HR 1.35 (95% CI:1.20; 1.55)). CONCLUSIONS: Patients with posterior UM have an increased risk of new primary cancer independent of SES. No difference in incidence of specific cancer type was observed compared to the control group.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article